SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001723128-19-000145
Filing Date
2019-12-17
Accepted
2019-12-17 17:44:23
Documents
1
Period of Report
2019-12-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_157662264303996.html 4  
1 FORM 4 wf-form4_157662264303996.xml 4 6466
  Complete submission text file 0001723128-19-000145.txt   7851
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Issuer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AMNEAL PHARMACEUTICALS, INC. 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address
George Jeffrey P. (Reporting) CIK: 0001796789 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38485 | Film No.: 191290716